Macrogenics (MGNX) EBIAT (2016 - 2025)
Historic EBIAT for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to $16.8 million.
- Macrogenics' EBIAT fell 7012.56% to $16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.9 million, marking a year-over-year increase of 2226.15%. This contributed to the annual value of -$67.0 million for FY2024, which is 63930.23% down from last year.
- According to the latest figures from Q3 2025, Macrogenics' EBIAT is $16.8 million, which was down 7012.56% from -$36.3 million recorded in Q2 2025.
- In the past 5 years, Macrogenics' EBIAT ranged from a high of $57.5 million in Q2 2023 and a low of -$66.4 million during Q1 2022
- Moreover, its 5-year median value for EBIAT was -$39.9 million (2021), whereas its average is -$24.1 million.
- Per our database at Business Quant, Macrogenics' EBIAT crashed by 268016.29% in 2021 and then soared by 23913.66% in 2023.
- Macrogenics' EBIAT (Quarter) stood at -$58.0 million in 2021, then surged by 122.06% to $12.8 million in 2022, then plummeted by 459.88% to -$46.1 million in 2023, then skyrocketed by 66.53% to -$15.4 million in 2024, then surged by 209.09% to $16.8 million in 2025.
- Its EBIAT stands at $16.8 million for Q3 2025, versus -$36.3 million for Q2 2025 and -$41.0 million for Q1 2025.